TimingTimingTiming Posted - 2 days ago

$INO Im gonna let you in on a little biotech secret. When considering a biotech (applies to other stocks too) look at the all-time chart. If the price now is in the single digits and the price going way back is extremely high (INO’s is over $1400 in February 2000), you have yourself a dilution machine - avoid it, period. Of course the stock price was never that high instead the stock price is suffering from a series of reverse splits completed by smart doctors who have no clue how to manage money. The good CEO’s do not kill the common shareholders with constant dilution they plan how to preserve cash until milestones are met that drive up value for shareholders and they raise capital on favorable terms. I mean look at these clowns raising capital in the $7 range when the stock has been trading over $11 lately. Idiots! $MNOV $KZIA

TimingTimingTiming Posted - 1 week ago

$MNOV Slow and Steady wins the race.

Train1980 Posted - 1 week ago

$MNOV Each time I see “you’re sitting on a gold mine” commercial, I remember MNOV M-001

Train1980 Posted - 1 week ago

$MNOV Come on management Let’s get trendy and test MN-001 for weight loss 🙏

Train1980 Posted - 2 weeks ago

$MNOV looks like we will have a gradual recovery until end of May/ beginning of June. At which time we get updates for both our NASH & Glioblastoma drugs. Then we hopefully 🤞 shoot up ⬆️

Stock_Titan Posted - 2 weeks ago

$MNOV MediciNova Announces Abstract Regarding Results of a Clinical Trial of MN-166 (ibudilast) in Glioblastoma Accepted for Presentation at the 2024 American Society of Clinical Oncology Annual Meeting (2024 ASCO) https://www.stocktitan.net/news/MNOV/medici-nova-announces-abstract-regarding-results-of-a-clinical-trial-z32rpq2coues.html

thepalace2007 Posted - 2 weeks ago

$MNOV easy 5 x from here small float news coming watch it run

Train1980 Posted - 03/27/24

$MNOV already 3 times our 10-day average volume

shared_alerts Posted - 03/27/24

-03/27/2024- 📉 MORNING GAPPERS CONT 📈 $MNOV $NUVB $GDC $PAYS ↩️

OpenOutcrier Posted - 03/27/24

$MNOV (+7.4% pre) MediciNova Receives a Notice of Allowance for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in Japan - SI https://ooc.bz/l/28830

TimingTimingTiming Posted - 03/27/24

$MNOV

Train1980 Posted - 03/27/24

$MNOV I don’t think 🤔 these historical low prices for MNOV are going to last long.

G101SPM Posted - 03/27/24

$MNOV $1.51 bid. BUY/NEW LONG POSITION carries SPM 81.47 tag to ERXIT at $2.70 in midterm.

topstockalerts Posted - 03/27/24

$MNOV keep an eye

AZOZ Posted - 03/27/24

Good morning 🌞 Small cap premarket movers $IBIO $CZOO $HKIT $MNOV $PIXY

PennyStocksMom Posted - 03/26/24

🌄 Watchlist ✅️ $MRDB support .40/45, resistance .55/.60, big float ✅️ $IBIO support mid 1.50/.55, resistance 1.75/.80, avoid chasing near resistance, avoid swing accumulation at current price, small float, announces 15m private placement ✅️ $ILAG still low volume, tight range, support .55/.60, resistance .70/.75, small float ✅️ $MNOV still low volume, mid 1.50/.55, resistance 1.60, heavy float ✅️ $CZOO small float

DonCorleone77 Posted - 03/26/24

$MNOV MediciNova gets notice of allowance from Japan for pending patent for MN-166 The company states: "MediciNova announced it has received a Notice of Allowance from the Japan Patent Office for a pending patent application which covers MN-166, or ibudilast, for the treatment of macular injury associated with progressive multiple sclerosis. Once issued, this patent is expected to expire no earlier than October 2039. The allowed claims cover the use of MN-166 for treating macular injury associated with progressive multiple sclerosis and for decreasing macular volume loss associated with progressive multiple sclerosis. The allowed claims specifically cover both primary progressive multiple sclerosis and secondary progressive multiple sclerosis. The allowed claims cover oral administration including tablets, capsules, granules, microbead dosage forms, and liquid dosage forms. The allowed claims cover a wide range of doses of MN-166 , a range of different dosing frequencies..."

dweber23 Posted - 03/26/24

$MNOV https://healthstockshub.com/news/nasdaq/mnov/medicinova-receives-a-notice-of-allowance-for-a-new-patent-covering-mn-166-ibudilast-for-the-treatment-of-macular-injury-in-japan

Stock_Titan Posted - 03/26/24

$MNOV MediciNova Receives a Notice of Allowance for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in Japan https://www.stocktitan.net/news/MNOV/medici-nova-receives-a-notice-of-allowance-for-a-new-patent-covering-t01o89cb1wzb.html

TimingTimingTiming Posted - 03/26/24

$MNOV The sellers are done. No one wants out. The losers left. Now the stock can launch. I have seen this several times before. Very low volume at the bottom. Easy money.

Train1980 Posted - 03/26/24

$MNOV I think we just need more people to know about the stock. Analyst upgrade or insider buying would make more people interested in buying

TimingTimingTiming Posted - 03/22/24

$MNOV This is actually my favorite stock - watch - I’m betting big here - calls and shares - Texas hedge

TimingTimingTiming Posted - 03/22/24

$MNOV

Train1980 Posted - 03/21/24

$MNOV looks like we’re on the right path, they’re following up with phase II for NASH and the chart looks better (forming double bottom at 1.3) Any thoughts?

TimingTimingTiming Posted - 03/21/24

$MNOV https://stocks.apple.com/Anr98sjkISm2_Plxa4AGTNw

Stock_Titan Posted - 03/20/24

$MNOV MediciNova Announces Two Abstracts regarding MN-001 (tipelukast) and MN-002 Accepted for Presentation at the 92nd EAS 2024 Congress, the Annual Meeting of the European Atherosclerosis Society https://www.stocktitan.net/news/MNOV/medici-nova-announces-two-abstracts-regarding-mn-001-tipelukast-and-hc4v73skpg9b.html

Train1980 Posted - 03/20/24

$MNOV For the Love of God, can someone tell management to focus on their valuable asset for NASH (Weight Loss potential) and leave chlorine gas alone!!! So we can smell money instead of gas from short sellers!!!!

Stock_Titan Posted - 1 month ago

$MNOV MediciNova Announces New Data and Results of MN-166 (ibudilast) in Chlorine Gas-induced Acute Lung Injury Presented at the 63rd Annual Meeting of the Society of Toxicology https://www.stocktitan.net/news/MNOV/medici-nova-announces-new-data-and-results-of-mn-166-ibudilast-in-kzrn6lm1v9rq.html

TimingTimingTiming Posted - 1 month ago

$MNOV possibly, CLNN is another ALS play

Train1980 Posted - 1 month ago

$MNOV are we up today because Amylyx failed its ALS trial?